HIGHLIGHTS
- who: Akhil Shukla and collaborators from the Department of Immunology and Cell Biology, Faculty of Medicine and Health Sciences, Centre Hospitalier de l`Universitu00e9 de Sherbrooke, Sherbrooke, QC J H, Canada have published the research: The MHC Class-I Transactivator NLRC5: Implications to Cancer Immunology and Potential Applications to Cancer Immunotherapy, in the Journal: (JOURNAL)
- what: The authors provide an overview of cancer immunity mediated by CD8+ T cells and functions of in antigen presentation pathways. The authors explore possible avenues of exploiting for cancer This study showed that the lncRNA XIST (X-inactivation-specific . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.